Saturday, December 06, 2025 | 05:47 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Madras HC maintains injunction barring Patanjali from using term Coronil

Court came down heavily on Patanjali for attempting to make profits by exploiting fear of Covid-19

Patanjali coronil
premium

The Order followed a petition filed by Patanjali Ayurved Ltd, seeking vacation of an ex-parte interim injunction granted by the Court on July 17

T E Narasimhan Chennai
The Madras High Court today refused to vacate an injunction restraining Patanjali from using the term Coronil to market its immunity-boosting tablets against Covid-19. Justice C V Karthikeyan of the High Court came down heavily on Patanjali in in his order today, for attempting to profit by exploiting the fear of Covid-19. He directed the firm to pay Rs 10 lakh towards costs to Cancer Institute, Adyar in Chennai and the Government Yoga & Naturopathy hospital.

The Order followed a petition filed by Patanjali Ayurved Ltd, seeking vacation of an ex-parte interim injunction granted by the Court on July 17,